2021-12-23

Contemporary OB/GYN: Not all HPV genotypes pose the same risk for disease

Contemporary Obgyn: Not all HPV genotypes pose the same risk for disease

Why do HPV tests with extended genotyping provide a more personalized assessment of an individual’s risk for developing cervical precancer? Discover the perspective of Molly Broache, Senior Manager, Medical Science Liaison at BD Life Sciences.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

BD blog: The future of cervical cancer screening: More genotypes means more precise care
Cervical Cancer | News & Updates
BD blog: The future of cervical cancer screening: More genotypes means more precise care
New study shows substandard approaches to diagnosis and treatment for vaginal discharge syndromes
Vaginitis | News & Updates
Press release: New study shows substandard approaches to diagnosis and treatment for vaginal discharge syndromes
BD submits pre-market approval supplement to FDA to enable ThinPrep® Pap Test™ PreservCyt® Solution to be used with the BD Onclarity™ HPV Assay
Cervical Cancer | News & Updates
Press release: BD submits pre-market approval supplement to FDA to enable ThinPrep® Pap Test™ PreservCyt® Solution to be used with the BD Onclarity™ HPV Assay